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Abstract  
This study examined the therapeutic effects of probiotic Dahi containing Lactobacillus acidophilus LaVK2 and Lactobacillus 
plantarum Lp9, alone or as well as in combination with piroxicam (PXC) as an antioxidant agent in male Wistar rats administered 
1, 2-dimethylhydrazine dihydrochloride (DMH). Colorectal carcinogenesis was induced by injecting DMH subcutaneously (40 
mg/kg body weight) twice a week for 2 weeks. The rats were fed with buffalo milk or probiotic Dahi alone or in combination with 
PXC in addition to basal diet ad libitum and euthanized at 8th, 16th and 32nd week of the experiment and examined for 
biochemical and histopathological profile. A significant reduction in lipid peroxidation measured as thiobarbituric acid reactive 
substances (TBARS) in liver and colorectal tissue, and carcinogen activating enzyme measured as β-glucuronidase activity in 
faeces were observed in probiotic Dahi-DMH-PXC group compared with the DMH control group. Probiotic Dahi alone or in 
combination with PXC was showed a significant (P < 0.05) protective effect by lowering the levels of TBARS, faecal 
β-glucuronidase and by enhancing the activity GST in liver and colorectal tissues, correlated with decreased tumor incidence, 
tumor multiplicity and tumor volume in gastrointestinal (GI) tract in DMH induced rats. These observations suggest that probiotic 
Dahi alone or conjointly with PXC may have therapeutic potential in attenuation of carcinogenesis in GI tract.  
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Colorectal cancer is the fourth most common cancer in 
men and the third most common cancer in women 
worldwide and is therefore a major health problem 
accentuating the need for effective chemopreventive 
strategies [1, 2]. The protective effect of nonsteroidal 
anti-inflammatory drugs, such as aspirin, piroxicam and 
sulindac, in colon cancer has been well documented in 
epidemiologic and animal studies [2]. In recent years, a 
substantial growing interest towards probiotics (live 
microorganism such as bacteria, beneficial to health, 
which when consumed in sufficient numbers confer 
health benefits by colonizing in the gut and inhibiting 
the growth of pathogenic organisms) has been 
developed throughout the world, leading to vigorous 
research on the relationship between diet, dietary 
constituents and their health benefits.  
Convincing studies suggests that probiotics modulate 
the host resistance against intestinal infections, to 
reduce the absorption of mutagens that could contribute 
to colon carcinogenesis [3], reduce DNA damage 
induced by chemical carcinogens in the colonic mucosa 
of rats [4] and provide protective effects against colon 
cancer development [3-5]. The colonic microbiota has 
been identified as being capable of influencing 
gastrointestinal diseases and disorders including that of 
colorectal cancer [6]. There exists a potential role for 
foods that contain probiotics and/or prebiotics to change 
the colonic microbiota in a way that might prevent 
diseases such as colorectal cancer [7-10]. 
Piroxicam (PXC; 
4-hydroxyl-2-methyl-N-2-pyridinyl-2H-1, 
2,-benzothiazine-3-carboxamide-1, 1-dioxide) a 
nonsteroidal anti-inflammatory drugs (NSAID) is 
non-selective COX inhibitor, widely used for treatment 
of inflammatory arthritis [6], has been regarded 
chemopreventive agent that inhibits 
methylazoxymethanol acetate-, methylnitrosourea-, and 
AOM-induced intestinal tumors in animal models [7, 8]. 
PXC not only prevent but also cause regression of 
precancerous lesions identified as aberrant crypt foci 
(ACF), both of which were associated with the 
prevention of colon tumors in azoxymethane 
(AOM)-induced colon cancer in rats [9]. PXC elevates 
detoxification potential of tissues from the 
gastrointestinal tract and oesophagus, by increasing the 
expression of glutathione-S-transferase (GST) in 
carcinogen induced gastrointestinal tumors in rats [10]. 
Thus, PXC may diminish the bioavailability of dietary 
carcinogen by impeding their absorption and by 
enhancing their removal through faeces leading to 
reduced oxidative stress and tumour formation. 
Recently, our laboratory have shown that the product 
under current investigation attenuates the diet induced 
hypercholesterolemia in rats [11], and improves 
macrophage activity and confers protection against 
enteric infection in mice [19]. It converses age related 
deregulation of tissue antioxidant activities and decline 
in expression of biomarkers of ageing (peroxisome 
proliferators activated receptors-α, senescence marker 
protein-30) in hepatic and kidney tissues [20] and 
alleviates age induced decline in macrophage and 
lymphocyte functions [12]. Dahi is fermented buffalo 
milk widely consumed in Indian sub-continent and is 
prepared using mesophillic culture of lactococci, which 
are not probiotic in nature. Being a fermented milk 
product, Dahi can be an excellent medium for delivery 
of probiotic strains that can provide protection against 
colorectal cancer. In this context, the present study was 
carried out for the first time to evaluate the protective 
role of probiotic Dahi and its intervention with PXC on 
DMH-induced colorectal carcinogenesis in male Wistar 
rats. 
Material and Methods 
Bacterial strains  
Lactococcus lactis ssp. cremoris NCDC-86 and 
Lactococcus lactis ssp. lactis biovar diacetylactis 
NCDC-60 were obtained from National Collection of 
Dairy Cultures, National Dairy Research Institute, 
Karnal, India. Lactobacillus plantarum Lp9 was a 
generous gift from Dr. V. K. Batish, Emeritus Scientist, 
Dairy Microbiology Division, NDRI, Karnal, India. 
Lactobacilli and lactococci were propagated and 
maintained in MRS-broth and M17 broth (Himedia 
Laboratories Pvt. Ltd., Mumbai, India) at 37 and 30°C, 
respectively and were stored at 4 to 8°C between 
transfers. L. plantarum and L. acidophilus were 
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propagated and cultured at 37ºC for 24 h and 37ºC for 
48 h, respectively.  
Preparation of Dahi and probiotic Dahi 
(LaLp Dahi)  
Bacterial cultures were revitalized three times in 
reconstituted and autoclaved skim milk prior to use for 
preparation of fermented milk. Buffalo milk obtained 
from the cattle yard of the institute and standardized to 
3.0% fat was heated to 90°C for 15 min and then cooled 
to 37°C. Dahi was prepared by culturing standardized 
buffalo milk with Dahi starter (Lactococcus lactis ssp. 
cremoris and Lactococcus lactis ssp. lactis biovar 
diacetylactis, 1% each) at 30°C for 8 h. Probiotic LaLp 
Dahi was prepared by culturing buffalo milk with L. 
acidophilus LaVK2, Lactobacillus plantarum Lp9 and 
Dahi culture (1.0%). The final product contained 2 x 109 
cfu/g of lactococci, L. plantarum and L. acidophilus 
each.  
Chemicals 
1, 2-dimethylhydrazine dihydrochloride (DMH), 
piroxicam (PXC), para-Nitrophenyl-β-D-glucuronide 
(pNPG) and para-Nitrophenol (pNP) were purchased 
from Sigma-Aldrich Chemical Co. (St. Louis, MO, 
USA) while, 1-chloro-2, 4-dinitrobenzene (CDNB), 
Thiobarbituric acid (TBA), EDTA, glutathione, 
para-nitrophenol, Potassium phosphate were purchased 
from Sisco Research Laboratories (Mumbai, India). All 
other chemicals were obtained from s.d. Fine Chemicals 
Ltd., Mumbai, India or Hi-Media Lab. Ltd., Mumbai, 
India.  
Animals and Diet 
Male Wistar rats 3 weeks of age were obtained from 
Animal House of NDRI, India, and maintained in a 
small animal house. The animals were housed in 
stainless steel cages (2 animals per cage) throughout the 
study, and the room temperature was maintained at 25 ± 
2ºC with 55 ± 5%  humidity and at a 12-hour 
light/12-hour dark cycle. The animals were used and 
cared for in accordance with the principles and 
guidelines for humane use, and the protocol was 
approved by the institutional ethics committee. The 
composition of basal diet was starch, 63%; casein, 20%; 
soybean oil, 5.5%; cellulose, 5%; mineral mixture, 5%; 
vitamin mixture, 1%; D-L methionine, 0.2%; and 
choline chloride, 0.2%. Salt mixture required for 10 kg 
diet (500g) contained CaCO3, 190.7g; CoCl2.6H2O, 
0.0115g; CuSO4.5H2O, 0.238g; FeSO4.7H2O, 13.5g; 
KH2PO4, 194.5g; KI, 0.4g; MgSO4.7H2O, 58.62 g; 
MnSO4.H2O, 2.005g; NaCl, 69.65g; and ZnSO4.7H2O, 
0.274g. Vitamin mixture (100g) comprised of biotin, 4 
mg; folic acid, 20 mg; vitamin B12, 0.3 mg; menadione, 
50 mg; para aminobezoic acid, 1 g; meso-inositol, 1 g; 
thiamine, 50 mg; riboflavin, 80 mg; pyridoxine, 50 mg; 
calcium pentothenate, 0.4g and starch, 76.946 g. 
Vitamin A (2 x 105 IU), vitamin E (103 IU) and vitamin 
D (2 × 104 IU) were administered to the diet through oil 
/ fat (for 10Kg diet).  
Experimental design  
Animals were randomly distributed into five groups, 
twenty four rats in each group and fed with the probiotic 
supplements (20 g) in addition to basal diet for 32 weeks. 
Rats of Group I was fed with buffalo milk (BM) which 
served as control group. Rats of group II was 
administered DMH and served as the DMH control; rats 
of group III (BM-DMH-PXC) was administered with 
BM and PXC in DMH induced rats. Rats of group IV 
were accessible to probiotic Dahi and DMH, and rats of 
group V were offered both probiotic Dahi and PXC in 
DMH induced rats. DMH (40 mg/kg body weight) was 
administered subcutaneously (s.c.) to the rats of 
corresponding groups at twice a week for 2 weeks [13]. 
PXC (4 mg/rat or 200 mg/kg of supplements) was given 
daily orally [14, 15] along with the supplements 
(milk/probiotic Dahi) and its feeding started one week 
after the last dose of DMH and continued till 
termination of experiment. Rats were sacrificed at 8, 16 
and 32 weeks of experimental time and colon and liver 
tissue were analyzed for thiobarbituric acid reactive 
substances (TARS) and glutathione-S-transferase 
activity. Faeces were collected by gently squeezing the 
rectum of rats in self sealer polypacks, immediately kept 
in ice and processed for β-glucuronidase activity.  
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Enzymatic assays 
The decreased levels glutathione-S-transferase (GST) 
and β-glucuronidase activities were reported in DMH 
induced rats. To evaluate, the effects of probiotic and 
PXC supplement to revert this effect and maintain the 
normal level of enzymes in DMH induced rats, 
enzymes like GST and β-glucuronidase activities were 
determined in requisite samples.  
Glutathione-S-transferase (GST) activity 
The assay of GST activity was based on that described 
by Habig et al [16]. It was based on an increase in 
absorbance at 340 nm owing to the formation of 
thio-diethyl ether (conjugation of substrate with 
glutathione). The GST activity was calculated using 
molar extinction coefficient of 9.6 mM-1 cm-1 and 
expressed as units/mg protein, where one unit is defined 
as the amount of enzyme catalyzing the formation of 1 
nmole of product per min.   
β-glucuronidase activity 
β-Glucuronidase activity was determined according to 
the method of Stossel modified by Perdigon et al. [17]. 
Freshly taken faeces (1g) was homogenized for 1 min 
with teflon pestle in chilled acetate buffer to a final 
volume of 30 ml, passed through surgical gauze and 
sonicated (Branson Sonic, Danburg, USA) for three 1 
min burst at 4°C and then centrifuged at 500 xg for 15 
min. Reaction mixture contained 0.1 ml of 5 times 
diluted supernatant from faecal homogenate, 0.15ml of 
acetate buffer and 0.25ml of pNPG incubated at 37°C 
for 5 h. The reaction was stopped with 1 ml of 0.1 M 
NaOH. The absorbance was read at 410 nm and the 
amount of pNP released determined using standard 
curve of pNP (1.39 to 11.1 µg). One unit of enzyme 
activity was defined as one nmoles of pNP liberated/h/g 
faeces. 
Thiobarbituric acid reactive substance content  
Lipid peroxidation products in liver and colorectal 
tissues were estimated as thiobarbituric acid-reactive 
substances (TBARS) as described by Uchiyama & 
Mahira [18] using malonyl dialdehyde (MDA) as a 
standard. Briefly, the samples treated with thiobarbituric 
acid containing butylhydroxytoluene (10 mM) and 
ferrous sulfate (200 mM) were incubated for 15 min in 
boiling water bath, and the difference in absorbance at 
520 and 535 nm was determined. The concentration of 
MDA determined from the standard curve prepared 
using 1, 1, 3, 3-tetraethoxypropane and expressed as 
nmoles of MDA per mg protein.  
Histopathological examination of 
colorectal tissue 
Colorectal tissue was collected after the viscera of 
euthanized animals from all experimental groups. The 
tissue was fixed in 10% formalin buffer, and was 
processed and embedded in paraffin following the 
standard protocols. The processed tissue was sectioned 
at 5 μm and stained with haematoxylin and eosin, and 
examined under light microscopy.  
Tumor incidence, multiplicity, volume, 
number and size  
The colorectal tissue was cut longitudinally for tumor 
analysis. The tumor number, location, incidence, 
multiplicity, size and volume were measured. The 
tumor volume was calculated by applying the following 
formula:  ν = π/6 x w x d, where l = length, w = width 
and d = depth [19]. 
Statistical analysis 
The results were expressed as mean ± SE for each group 
(n=8) and analyzed by One-way analysis of variance 
(ANOVA) followed by the Tukey post hoc test 
(SYSTAT version 6.0.1, SPSS Inc, Chicago, IL, USA). 
Differences were considered significant at P < 0.05. 
Results 
Effect on feed intake on body weight  
A significant decline in average feed intake was 
observed in rats treated with DMH (Table 1). Treatment 
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of DMH induced rats with either LaLp Dahi or PXC 
alone or LaLp Dahi adjuvant with PXC, restored feed 
intake to normal levels and increased body weight 
significantly (P< 0.05).  
Effect on tumor incidence, multiplicity, 
volume, number and size 
Table 2 and 3 summarized the data on incidence, 
multiplicity, volume, number and size of tumors in 
colorectum which clearly indicate the protective 
potential of LaLp Dahi and PXC against colorectal 
carcinogenesis. The proportion of rats that developed 
tumors in any part of GI tract was 90% in DMH treated 
control group, which was significantly (P<0.5) reduced 
to 65%, 60%, 20% and 25% in rats treated with Buffalo 
milk and piroxicam, LaLp Dahi and LaLp Dahi in 
combination with PXC, respectively, and the 
differences were not statistically significant among 
groups treated with PXC or LaLp Dahi. The rats treated 
with PXC in combination with LaLp Dahi registered 
further decline in tumor incidence. There was no 
significant difference in tumor multiplicity between 
DMH treated control group and the groups treated with 
PXC or LaLp Dahi, however the animals treated with 
the combinations of PXC and probiotic LaLp Dahi 
registered significantly lower tumor multiplicity. The 
average tumor volume per tumor decreased (55% to 
59%) significantly (P<0.5) in rats treated with PXC, 
LaLp Dahi, and the difference among these groups was 
not statistically significant.  
 
 
 
 
 
Table 1 Effect of feeding probiotic Dahi and piroxicam (PXC) treatment on feed intake and body weight of dimethylhydrazine 
(DMH) treated rats 
 Body weight (g) 
 Average feed intake 
(g/d/rat) 
Initial Final Gain 
Groups Mean SEM Mean SEM Mean SEM Mean SEM 
BM 17.8a 1.9 22.2a 0.3 325.2a 1.0 303.0a 1.0 
BM-DMH 11.4b 2.0 22.8a 0.4 237.0b 3.5 214.3b 3.6 
BM-DMH-PXC 16.8a 2.0 23.2a 0.4 304.5c 3.1 281.3c 3.2 
LaLp Dahi-DMH 16.2a 1.9 23.1a 0.3 324.9a 1.4 301.8a 1.4 
LaLp Dahi-DMH-PXC 17.0a 2.0 23.1a 0.4 343.6d 6.1 320.5d 5.9 
BM, Buffalo milk; PXC, piroxicam; DMH, 1,2- dimethylhydrazine Values are mean ± SE for n=20. a,b,c,d Values within column 
with different superscript letters are significantly different (P<0.05) 
 
Table 2 Effect of feeding probiotic Dahi and piroxicam (PXC) treatment on tumor incidence and total number of tumors in 
gastrointestinal tract of rats injected with dimethylhydrazine (DMH) 
 
    Treatment  
 BM BM-DMH BM-DMH--PXC LaLp Dahi-DMH LaLp Dahi-DMH-PXC 
Gastrointestinal tract      
Tumor incidence 0 18 / 20 (90%)a 13 / 20 (65%)ab 12 / 20 (60%)b 4 / 20 (20%)c 
Total tumor number 0 47 26 25 4 
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    Treatment  
 BM BM-DMH BM-DMH--PXC LaLp Dahi-DMH LaLp Dahi-DMH-PXC 
Colorectum      
Tumor incidence 0 18 / 20 (90%)a 13 / 20 (65%)ab 12 / 20 (60%)b 4 / 20 (20%)c 
Total tumor number 0 31 18 18 4 
Caecum      
Tumor incidence 0 9 / 20 (45%) 5 / 20 (25%) 5 / 20 (25%) 0 / 20 (0%) 
Total tumor number 0 10 8 7 0 
Small Intestine      
Tumor incidence 0 2 / 20 (10%) 0 / 20 (0%) 0 / 20 (0%) 0 / 20 (0%) 
Total tumor number 0 3 0 0 0 
Stomach      
Tumor incidence 0 2 / 20 (10%) 0 / 20 (0%) 0 / 20 (0%) 0 / 20 (0%) 
Total tumor number 0 3 0 0 0 
BM, Buffalo milk; PXC, piroxicam; DMH, 1,2- dimethylhydrazine 
# Tumors number per tumor bearing rat.; a,b,c,d Values within row with different superscripts letters are significantly different 
(P<0.05).  
 
Table 3 Effect of feeding probiotic Dahi and piroxicam (PXC) treatment on tumor multiplicity and average tumor volume in 
gastrointestinal tract of rats injected with dimethylhydrazine (DMH) 
 
Treatment 
 BM BM-DMH BM-DMH-PXC LaLp Dahi-DMH LaLp Dahi-DMH-PXC 
Gastrointestinal tract  Mean SEM Mean SEM Mean SEM Mean SEM 
Tumor multiplicity# 0 2.61a  0.47 2.0a 0.16 2.08a  0.27 1.0b  0.0 
Av. tumor volume (mm3) / tumor 0 86.8a  19.3 35.5b 6.2 37.7b 8.0 3.93c 1.0 
Av. tumor volume (mm3) / tumor bearing animal 0 226.6a  36.5 71.1b 13.3 78.5b   19.4 3.93c   1.0 
Colorectum          
Tumor multiplicity# 0 1.72a  0.24 1.38ab 0.13 1.5ab  0.16 1.0b  0.10 
Av. tumor volume (mm3) / tumor 0 27.9a  3.6 20.3ab 3.0 16.0b  2.4 3.93c   1.0 
Av. tumor volume (mm3) / tumor bearing animal 0 48.1a  8.7 28.1ac 6.4 24.0ac  7.3 3.93b  1.4 
Caecum          
Tumor multiplicity# 0 1.11a  0.12 1.6a 0.25 1.4a  0.19 0 0 
Av. tumor volume (mm3) / tumor 0 287.4a  56.0 69.84b 12.5 93.5b  11.1 0 0 
Av. tumor volume (mm3) / tumor bearing animal 0 318.9a  
 
63.3 73.0b 
 
15.2 131.0c  
 
19.5 0 0 
Small Intestine          
Tumor multiplicity# 0 1.5  0.4 0 0 0 0 0 0 
Av. tumor volume (mm3) / tumor 0 65.0  11.7 0 0 0 0 0 0 
Av. tumor volume (mm3) / tumor bearing animal 0 97.4  20.7 0 0 0 0 0 0 
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Stomach          
Tumor multiplicity# 0 1.5 0.5 0 0 0 0 0 0 
Av. tumor volume (mm3) / tumor 0 49.2 3.7 0 0 0 0 0 0 
Av. tumor volume (mm3) / tumor bearing animal 0 73.9 15.4 0 0 0 0 0 0 
BM, Buffalo milk; PXC, piroxicam; DMH, 1,2- dimethylhydrazine# Tumors number per tumor bearing rat. a,b,c,d Values within 
row with different superscripts letters are significantly different (P<0.05). Data for tumor multiplicity and tumor volume were 
compared by unpaired student t-test and tumor incidence by z test. 
 
In animals treated with PXC in combination with 
LaLp Dahi, the average tumor volume per tumor 
decreased by 92-95%. The average tumor volume per 
tumor bearing animals in DMH treated rats was 227 
mm3 which was reduced to 71-79 mm3 in animals 
treated with PXC and LaLp Dahi. The treatment with 
PXC in combination with LaLp Dahi resulted in 96 to 
98% reduction in average tumor volume per tumor 
bearing animal. 
Colorectum 
The effect of treatment with piroxicam or probiotic 
Dahi or with combination of these two in tumor 
incidence in colorectum was similar to that in entire GI 
tract explained as above. The tumor multiplicity in 
colorectum in animals treated with DMH was 1.7, 
which decreased by feeding PXC, LaLp Dahi or 
combination of PXC with probiotic Dahi. The decline 
in tumor multiplicity could reach to the level 
statistically significant only in animals treated with 
combination of PXC and LaLp Dahi. The average 
tumor volume per tumor and tumor load per tumor 
bearing animal in DMH treated control group were 27.9 
mm3 and 48.1 mm3, respectively, which declined 
significantly by treatment with LaLp Dahi; and the 
treatment with combination of PXC and probiotic Dahi 
was more effective in reducing tumor volume.  
Caecum  
The caecum was the other major site where tumor 
appeared in large number as results of treatment with 
DMH, and the incidence was half of that in colorectum. 
The tumor incidence in caecum decreased by 22% in 
rats treated with PXC or LaLp Dahi, and no tumor 
appeared in caecum in rats treated with PXC in 
combination with LaLp Dahi. The average tumor 
volume per tumor or tumor load per tumor bearing rat 
also decreased significantly by treatment with PXC or 
probiotic Dahi.  
Small intestine and stomach 
The incidence of tumor in small intestine and stomach 
was 10%, and no tumor appeared in this segment of GI 
tract in rats treated with PXC or probiotic Dahi. 
 
Table 4 Effect of feeding probiotic Dahi and piroxicam (PXC) treatment on glutathione-S-transferase activity and the level of 
thiobarbituric acid-reactive substances (TBARS) in the liver of rats administered dimethylhydrazine (DMH)  
        Treatment    
Parameters Duration 
Weeks 
BM 
BM-DMH BM-DMH-PXC LaLp Dahi-DMH LaLp 
Dahi-DMH-PXC 
  Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM 
GST (mg protein) 0 75A 4 75A 4 75A 4 75A 4 75A 4 
 8 118a,B 1 60b,B 1 80c,A 2 99d,B 1 103d,A 2 
 16 225a,C 4 107b,C 4 125c,B 2 126c,C 3 203d,B 11 
 32 271a,D 11 187b,D 5 205b,C 8 257a,D 6 511c,C 28 
TBARS (nmoles/g 
tissue) 
0 11.6A 1.1 11.6A 1.1 11.6A 1.1 11.6A 1.1 11.6A 1.1 
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        Treatment    
Parameters Duration 
Weeks 
BM 
BM-DMH BM-DMH-PXC LaLp Dahi-DMH LaLp 
Dahi-DMH-PXC 
  Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM 
 8 22.2a,B 1.1 81.1b,B 2.0 44.3c,B 2.3 37.7d,B 1.7 29.9e,B 1.6 
 16 26.2a,C 1.2 87.7b,C 2.6 65.6c,C 1.7 39.9d,B 1.9 34.0e,B,C 1.9 
 32 27.7a,C 1.5 118.9b,D 1.8 73.3c,D 2.3 50.5d,C 2.0 38.4e,C 2.2 
Values are mean ± SE for n=8. BM, Buffalo milk; PXC, piroxicam; DMH, 1,2- dimethylhydrazine; GST, 
glutathione-S-transferase; TBARS, thiobarbituric acid-reactive substances. *One unit is defined as one nmole of product 
formed/min.  a,b,c,d,e Values within a row with unlike superscripts letters were significantly different (P<0.05).  A,B,C,D Values in 
column with unlike superscripts letters are significantly different (P<0.05). 
 
Effect on glutathione-S-transferase activity 
Glutathione-S-transferase (GST) activity in liver at 
different time intervals in normal and in DMH injected 
rats has been shown in Table 4. The 
glutathione-S-transferase (GST) activity in liver 
increased with the age of normal untreated animal 
reaching at 32 week 10 fold of that at day 0. The 
treatment with DMH decreased substantially the age 
related increase in hepatic GST activity. The GST 
activity in liver decreased in DMH treated animal by 
49.2, 52.4, and 31.0% at 8th, 16th and 32nd week, relative 
to age matched untreated controls. The treatment of 
animals with PXC or feeding with probiotic Dahi, 
reversed to some extent the DMH induced decline in 
GST activity in liver. PXC and probiotic Dahi was 
similarly effective in reversing DMH induced decline in 
GST activity in liver at 8th and 16th week of 
experimental period. At 32 week, the effect of probiotic 
Dahi was more pronounced than that of PXC, and GST 
activity in former groups reached to the levels similar or 
even above the level in age matched untreated control 
group. In animals treated with combinations of PXC or 
probiotic Dahi the increase in GST activity in liver was 
greater than in animals treated with PXC or probiotic 
Dahi individually. At 32 week of experimental period, 
the GST activity in liver was significantly greater in 
animals fed with probiotic Dahi in combination with 
PXC than in age matched untreated control. The 
treatment with LaLp Dahi along with PXC was most 
effective in enhancing hepatic GST activity. 
 
Table 5 Effect of feeding probiotic Dahi and piroxicam (PXC) treatment on glutathione-S-transferase activity and the level of 
thiobarbituric acid-reactive substances (TBARS) in the colorectal tissue of rats administered dimethylhydrazine (DMH)  
 
        Treatment    
Parameters Duration 
Weeks 
BM 
BM-DMH BM-DMH-PXC LaLp Dahi-DMH LaLp 
Dahi-DMH-PXC 
  Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM 
GST (units/mg 
protein) 
0 20.1A 1.2 20.1A 1.2 20.1A 1.2 20.1A 1.2 20.1A 1.2 
 8 28.1a,d,B 0.9 20.8b,A 0.4 21.3b,A 0.5 25.7d,A 0.7 35.7c,B 1.5 
 16 37.3a,C 1.7 25.6b,B 1.5 29.1b,B 2.3 44.2a,B 2.1 69.0c,C 4.4 
 32 57.2a,c,D 2.7 34.8b,C 1.5 48.1a,C 3.2 62.9c,C 3.8 88.4d,D 3.6 
TBARS 
(nmoles/g 
tissue) 
0 3.26A 0.33 3.26A 0.33 3.26A 0.33 3.26A 0.33 3.26A 0.33 
 8 4.43a,B 0.33 14.10b,B 0.33 9.01c,B 0.35 7.22d,B 0.35 5.91e,B 0.23 
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        Treatment    
Parameters Duration 
Weeks 
BM 
BM-DMH BM-DMH-PXC LaLp Dahi-DMH LaLp 
Dahi-DMH-PXC 
 16 4.87a,B 0.26 21.08b,C 0.29 14.77c,C 0.28 9.67d,C 0.33 7.01e,C 0.33 
 32 6.58a,C 0.26 31.27b,D 0.41 22.09c,D 0.34 11.34d,D 0.37 8.67e,D 0.29 
Values are mean ± SE for n=8. BM, Buffalo milk; PXC, piroxicam; DMH, 1,2- dimethylhydrazine; GST, 
glutathione-S-transferase; TBARS, thiobarbituric acid-reactive substances.*One unit is defined as one nmole of product 
formed/min. a,b,c,d,e Values within a row with unlike superscripts letters were significantly different (P<0.05). A,B,C,D Values in 
column with unlike superscripts letters are significantly different (P<0.05). 
 
Table 6 Effect of feeding probiotic Dahi and piroxicam (PXC) treatment on β-glucuronidase activity in faeces of rats 
administered dimethylhydrazine (DMH)  
Values are mean ± SE for n=8. BM, Buffalo milk; PXC, piroxicam; DMH, 1,2- dimethylhydrazine *One unit is defined as one 
nmoles of pNP liberated/h/mg protein. a,b,c,d,e Values within a row with unlike superscripts letters were significantly different 
(P<0.05). A,B,C,D Values in column with unlike superscripts letters are significantly different (P<0.05). 
 
Table 5 shows the effect of treatment with PXC or 
feeding probiotic Dahi on GST activity in colorectal 
tissue. The GST activity in colorectal tissue in normal 
rats increased with age, and the treatment with DMH 
significantly reduced the age related rise in GST activity 
in colorectal tissue. The GST activity at 32 week in 
DMH treated control was only 73% above the day 0 
level compared to 185% above the day 0 level observed 
in untreated control rats. The treatment with PXC or 
feeding probiotic Dahi resulted in significant increase in 
GST activity in colorectal tissue in DMH treated rats. 
The probiotic Dahi was more effective than PXC in 
enhancing the GST activity in colorectal tissue. When 
animals were treated with combination of probiotic 
Dahi and PXC, the GST activity in colorectal tissue, 
increased even beyond the levels in age matched 
untreated normal animals, reaching at 32 week more 
than 400.0% of that at day 0.  
Effect on β-Glucuronidase activity  
β-glucuronidase is a bacterial enzyme that hydrolyses 
many glucuronides, and liberates carcinogenic 
aglycones in the intestinal lumen. Effect of PXC or 
probiotic Dahi treatment on the activity of 
β-glucuronidase in faeces of rats at different time 
intervals of experimental period has been shown in 
Table 6. The activity of β-glucuronidase in faeces was 
increased with age (43.0%) at 32 week above the day 0 
level. Treatment of rats with DMH result in increased 
activity of β-glucuronidase in the faeces by 3.3, 4.9, and 
6.0 fold at 8th, 16th and 32nd week, respectively. 
The treatment with PXC or feeding probiotic Dahi or 
combination of these two attenuated the rise in DMH 
induced β-glucuronidase activity in faeces. The 
probiotic LaLp Dahi was more effective than PXC in 
        Treatment    
Parameters Duration 
Weeks BM 
BM-DMH BM-DMH-PXC LaLp Dahi-DMH LaLp Dahi-DMH-PXC 
  Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM 
βglucuronidase* 0 192A 8 192A 8 192A 8 192A 8 192A 8 
 8 196a,A 5 917b,B 69 627c,B 7 449d,e,B 10 419d,B 6 
 16 223a,B 5 1141b,C 68 576c,C 23 416d,C 5 327e,C 4 
 32 279a,d,C 5 1336b,D 69 528c,D 14 363a,D 10 202d,D 9 
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attenuation of DMH induced rise in β-glucuronidase 
activity in faeces. The combination of probiotic Dahi 
and PXC was more efficacious than these two when fed 
alone, in attenuation of DMH induced rise in 
β-glucuronidase activity in faeces. Feeding DMH 
treated rats with LaLp Dahi or combination of probiotic 
Dahi with PXC brought down the activity of 
β-glucuronidase in faeces at 32 week of experimental 
period at level similar to age matched untreated normal 
animals. 
Effect on thiobarbituric acid reactive 
substances levels 
Accumulation of thiobarbituric acid reactive substances 
(TBARS), represent lipid peroxidation, is considered 
one of the mechanisms involved in the pathogenesis of 
inflammation, cancer and atherosclerosis. Depicted in 
Table 4 are the results of the effect of treatment with 
PXC or feeding probiotic Dahi or combination of these 
two on accumulation of TBARS in liver at different 
time intervals. The accumulation TBARS in liver was 
increased (139 %) with the age at 32 week above 0 d 
level. The treatment of animals with DMH increased 
accumulation of TBARS in liver by 256, 235 and 
329 % at 8, 16 and 32 week, respectively, relative to age 
matched untreated control. The treatment of animals 
with PXC or feeding with probiotic Dahi significantly 
attenuated the DMH induced rise in accumulation of 
TBARS in liver; and the probiotic Dahi was more 
effective than PXC. Further, greater reduction in 
TBARS accumulation in liver was observed when 
probiotic Dahi were fed in combination with PXC. The 
treatment with PXC in combination with feeding LaLp 
Dahi was more effective in reducing the accumulation 
of TBARS in liver. 
Table 5 shows the effect of treatment with PXC or 
feeding probiotic Dahi or combination of the two, on 
accumulation of TBARS in colorectal tissue of DMH 
induced rats. Like in liver, the accumulation of TBARS 
in colorectal tissue increased with age of animal 
reaching at 32 week at level almost double the level at 
day 0. The treatment with DMH resulted in 218, 333 
and 375% rise in accumulation of TBARS in colorectal 
tissue at 8, 16 and 32 week, respectively, compared with 
age matched untreated controls rats. The treatment with 
PXC or feeding probiotic Dahi or combination of the 
two significantly attenuated the DMH induced rise in 
accumulation of TBARS in colorectal tissue. Probiotic 
Dahi was more effective than PXC in attenuation of 
DMH induced accumulation of TBARS in colorectal 
tissues. When probiotic Dahi were given in combination 
of PXC, the reduction in TBARS accumulation was 
more pronounced.  
Histopathological examination 
Table 7 represents the histological analysis of tumors 
and distribution into adenoma, adenocarcinoma and 
carcinoma. In DMH control group, 16.1% tumors were 
carcinoma which reduced to 5.6% in PXC treated rats, 
and no carcinoma was seen in probiotic Dahi fed 
animals. The proportion of adenocarcinoma was also 
reduced significantly by treatment with PXC. On the 
other hand, the greater proportion of tumors in rats 
treated with PXC or probiotic Dahi or combinations of 
these two were of adenoma type, relative to DMH 
treated control rats. These results show that PXC 
treatment attenuated the progression of DMH induced 
tumors, and the probiotic Dahi improved the efficacy of 
PXC treatment. In DMH induced animals treated with 
combination of PXC and LaLp Dahi, all tumors were of 
adenoma type and did not progress further to 
adenocarcinoma.  Adenoma was defined histologically 
as lesions in which neoplastic cells were confined to 
mucosal layer and characterized by benign neoplasm of 
both solid and surface glandular epithelia which 
includes non-invasive growth, well defined margins of 
tumors, localized cell growth, cellular dysplasia, few 
mitotic figures, and normal to slight increase in ratio of 
nucleus to cytoplasm. Adenocarcinoma (where 
neoplastic cells had penetrated the muscularis mucosa 
to invade the submucosa or deeper layers) was 
characterized by tumors of glandular epithelium with 
irregular malignant glands, varying sizes, dark nuclei, 
multiple layers of cells, lack of mucin producing cells. 
The carcinoma was characterized by malignant tumor 
of colonic epithelium with invasive growth, uniform 
glandular structures, localization of nuclei to the basal 
half of the neoplastic cells, poorly defined margins of 
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tumors, failure of cellular differentiation, many mitotic 
figures, high nuclear to cytoplasmic ratio, loss of 
polarity of the nuclei, cells vary in shape and size 
(cellular polymorphism) and nuclear polymorphism. 
 
Table 7 Effect of feeding probiotic Dahi and piroxicam (PXC) treatment on progression of tumors in colorectum in DMH 
administered rat  
 
 
 
 
 
 
a,b,c,d,e Values within column with different superscripts letters are significantly different (P<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Longitudinal section of colonic mucosa stained with haematoxylin and eosin. (A) Normal looking colonic mucosa (200 
X); (B) Colonic mucosa showing crypt disarray, atypical cells lining the surface, narrow or deeper colonic crypts and 
inflammatory cell infiltration in lamina propria (200 X); (C) Crypts are smaller than normal, variable in shape, crypt loss, 
inflammatory infiltration, crypts abscess, deep invasion of the submucosal layer and show branching (200 X); (D) There is loss 
of normal crypt architecture with widening of lamina propria and mild nuclear polymorphism. Submucosa reveals dense 
lymphomononuclear infiltrate (200 X); (E) Longitudinal section of colonic mucosa stained with haematoxylin and eosin showing 
architectural distortion of colonic crypts and nuclear pleomorphism (200X). Colonic mucosa showing architectural distortion, 
dysplasia, colonic microadenoma crypts with focal loss of polarity of lining cells and mild nuclear pleomorphism; (F) 
Longitudinal section of colonic mucosa stained with haematoxylin and eosin showing severe dysplasia and lymphoid follicle 
(LF) surrounded by normal crypts (N) (200X). Haphazard arrangement of crypts lining epithelium shows, nuclear stratification, 
hyperchromasia, loss of polarity, focal crowding and back to back arrangement and inflammatory infiltrate. 
 
Histological sections of normal rats from buffalo 
milk-fed group displayed normal colonic architecture 
(Figure 1A); Most of the colonic mucosal sections in 
DMH treated control rats exhibited the atypical cells 
lining the surface, nuclear elongation, loss of polarity, 
mild atypia, narrow and deeper colonic crypts (Figure 
1B); crypt loss, inflammatory infiltration, crypts abscess 
and deep invasion of the submucosal layer by aberrant 
colonic crypts (Figure 1C); focal loss of polarity of 
lining cells and mild nuclear polymorphism (Figure 
1D); dysplasia and colonic microadenoma (Figure 1E). 
Dysplasia (loss of arrangement of cells) and hyperplasia 
Group Adenoma (%) Adenocarcinoma (%) Carcinoma (%) 
Buffalo milk 0 0 0 
Buffalo milk-DMH 51.6a 32.3a 16.1a 
Buffalo milk-DMH-PXC 61.1b 3.3b 5.6b 
LaLp Dahi-DMH 77.8c 22.2c 0 
LaLp Dahi-DMH-PXC 100.0d 0 0 
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(abnormal multiplication of cells within defined area) 
were common features in DMH treated groups. Figure 2 
(A & B)  depicts adenocarcinoma in colon of buffalo 
milk fed DMH treated rats, showing irregular malignant 
glands (G), varying in size, dark nuclei, multiple layers 
of cells, lacking mucin producing cells; hyperchromatic 
nuclei with high nucleus to cytoplasmic ratio. Figure 2 
(C &D) represents the tubulovillous adenoma having 
stalk covered with normal colonic-type mucosa that 
contrasts markedly from densely staining dysplastic 
epithelium of adenoma and Sessile villous adenoma 
(which is composed of frond-like outgrowths of 
epithelial cells supported by delicate connective tissue 
stroma giving a papillary shape) in neoplastic mucosa 
of buffalo milk fed DMH treated rats. Figure 2 (E & F) 
shows a well-differentiated carcinoma of colon in 
buffalo milk fed DMH treated rats (wherein the 
neoplasm forms uniform gland structures, and the 
nuclei are localized to the basal half of the neoplastic 
cells) and moderately differentiated carcinoma (wherein 
the neoplasm is composed of complex glandular 
structures, with loss of polarity of the nuclei). In Figure 
3 micrograph showing longitudinal section of colonic 
mucosa in LaLp Dahi-DMH and LaLp 
Dahi-DMH-PXC treated rats. (A; 200X & B; 200X) 
Section showing normal colonic crypt architecture with 
uniform appearing normal colonic glands stained in 
LaLp Dahi-DMH treated rat. (C & D; 200X) Section 
shows normal colonic glands with adequate goblet cell 
population in LaLp Dahi-DMH treated rats. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Micrograph showing longitudinal section of neoplastic mucosa in DMH treated rats (A & B) Longitudinal section of 
colon adenocarcinoma stained with haematoxylin and eosin in DMH treated rats showing malignant glands (G) irregular in 
shapes, varying sizes, with dark nuclei and loss of normal colonic architecture (200X); (C) A tubulovillous adenoma with stalk 
covered by normal colonic-type mucosa that contrast markedly with the densely staining dysplastic epithelium of the adenoma 
(200X); (D) Sessile villous adenoma composed of frond-like outgrowths of epithelial cells supported by a delicate connective 
tissue stroma giving a papillary shape (200X); (E) Micrograph showing well-differentiated carcinoma of colonic mucosa in 
DMH treated rats. The neoplasm forms uniform glandular structures, and the nuclei are localized to the basal half of the 
neoplastic cells (200X). (F) Moderately differentiated carcinoma. The neoplasm is composed of complex glandular structures, 
with loss of polarity of the nuclei and tumor cells lying singly and in groups (200X). 
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Figure 3 Micrograph showing longitudinal section of colonic mucosa in LaLp Dahi-DMH and LaLp Dahi-DMH-PXC treated 
rats. (A; 200X & B; 400X) Section showing normal colonic crypt architecture with uniform appearing normal colonic glands 
stained in LaLp Dahi-DMH treated rat. (C & D; 400X) Section shows normal colonic glands with adequate goblet cell 
population in LaLp Dahi-DMH treated rats. 
Discussion 
The present study aims to explore the protective effect 
of probiotic LaLp Dahi alone as well as in combination 
with PXC on experimental colorectal damage caused by 
DMH in rats. In the present study, feeding of probiotic 
LaLp Dahi alone, as well as in combination with PXC, 
was profoundly decreased in tumor incidence and lower 
tumor load as compared to animals received DMH 
alone; suggesting that probiotic Dahi may have 
protective effects against DMH induced colorectal 
carcinogenesis. Furthermore, conjointly administration 
of PXC with probiotic Dahi registered further abridged 
in tumor incidence and tumor multiplicity, suggesting 
for their synergistic effect. These results are in 
agreement with the protective role of lactic acid bacteria 
against the development of colon tumours [20, 21]. 
Probiotic LaLp Dahi significantly (P<0.05) 
decreased the DMH induced progression of aberrant 
crypt foci (ACF). Piroxicam (PXC) treatment also 
decreased the numbers of ACF; and the effect of PXC 
and probiotic Dahi was additive. The numbers of ACF 
having multiple aberrant crypts were very few in rats 
fed probiotic Dahi or treated with PXC or with 
combination of probiotic Dahi and PXC, while in DMH 
treated control these increased linearly with time (data 
not shown). Feeding probiotic Dahi to DMH induced 
rats decreased significantly (P<0.05) the induction and 
progression of mucin depleted foci (MDF). The 
treatment with PXC also decreased the induction and 
progression of DMH induced MDF, and the probiotic 
Dahi improved its efficacy (data not shown). The 
proliferating cell nuclear antigen (PCNA) index, a 
marker of carcinogenesis in GI tract, increased 
progressively in rats challenged with DMH. The 
treatment with probiotic Dahi or with PXC was equally 
effective in preventing the rise in PCNA index in DMH 
treated rats. Further, PXC and probiotic Dahi acted 
synergistically in preventing the rise in PCNA labelling 
index (data not shown).  
Feeding probiotic Dahi to DMH induced rats 
inhibited the progression of adenoma to carcinoma, and 
the significant inhibition (P<0.05) was also observed by 
treatment with PXC. These results are similar to those 
observations where administration of probiotics in 
animals have been reported to prevent 
carcinogen-induced aberrant crypt foci formation, 
reduce tumor incidence, tumor volume and tumor 
multiplicity and increase animal survival rate [22, 23]. 
The mechanism could possibly involve cellular uptake 
of carcinogen metabolites by lactic culture cells [24]. 
Non-lethal and inheritable mutations in cells mediated 
by the interaction of carcinogen such as DMH with 
DNA are the initial even in the initiation of cancer. The 
necessary step for this process is the generation of DMH 
metabolites such as methyldiazonium ions and 
carbonium ions, which are active carcinogenic 
electrophiles enter the intestine primarily via blood 
system or in small proportion in the bile that manifest 
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their action in colon [23]. These metabolites are able to 
methylate the DNA. An increase in O6-methylguanine 
(O6-MeG) lesions has been shown following treatment 
with DMH, and this DNA damage was found primarily 
in the colon [23, 25]. Also, DMH can be metabolized to 
a methyl free radical or hydrogen peroxide in the 
presence of metal ion that may contribute to the 
initiation of lipid peroxidation [26]. Pochart et al.  
suggested that the lactic cultures colonizing the colon, 
may bind to methylazoxymethanol which is released 
into the intestinal lumen thereby minimizing its 
re-absorption into the circulation by physically 
removing it via faeces [27]. In the present study, it might 
be possible that the metabolites produced by probiotic 
Dahi alone or in combination of PXC could be involved 
in the protective role of probiotic Dahi against colorectal 
cancer. 
GST is one of the important carcinogen detoxifying 
enzymes located almost in every organ, and present in 
large amounts in liver [20]. It is the 
detoxification/biotransformation enzyme involved in the 
detoxification of toxic substances such as xenobiotics, 
carcinogens, free radicals and peroxides by conjugating 
these substances with GSH [10]. In the present study, 
the GST activity in liver and colorectal tissue increased 
with age, and the treatment with DMH decreased 
substantially this age related increase in GST activity. 
The treatment of animals with PXC or feeding probiotic 
Dahi, reversed the DMH induced decline in GST 
activity in liver and colorectal tissue, and the treatment 
with combined PXC and probiotic Dahi was more 
effective. Thus, significant (P<0.05) decrease in GST 
activity in liver and colorectal tissues of tumor-bearing 
rats may be due to their utilization in detoxification of 
carcinogenic metabolites of DMH. Similar to our results, 
the treatment with piroxicam has been reported to 
elevate the detoxification potential of gastrointestinal 
tissue by increasing the expression of GST in carcinogen 
induced rats [28]. A significant reduction (P<0.05) in the 
activity GST in the DMH-treated group as compared to 
control and treatment groups (Table 5) could be 
responsible for the increased levels of TBARS observed 
during DMH-induced colorectal damage. GST enhances 
the biotransformation of carcinogens [29]. Induction of 
enzymes that are involved in the biotransformation of 
carcinogens may accelerate the metabolic disposal of 
carcinogens [30]. Hence, induction of GST by probiotic 
Dahi or PXC in DMH-treated rats might lead to 
metabolic disposal of DMH and its metabolites, 
resulting in the protection of liver as well as colorectal 
tissues and simultaneous inhibition of colon 
tumorigenesis.  
Our results also suggested that the detoxifying 
capacity of probiotic Dahi is comparable with that of our 
reference compound PXC. PXC elevate the 
detoxification potential of tissues from the 
gastrointestinal tract and oesophagus, by increasing the 
expression of GST in carcinogen induced 
gastrointestinal tumors in male Wistar rats [28]. 
Recently, the authors laboratory has shown that 
probiotics down-regulate carcinogen activating 
cytochrome P450 enzymes CYP1A1, CYP1A2 and 
CYP1B1 in the liver, upregulate carcinogen detoxifying 
γ-glutamyltranspeptidase, UDP-glucuronosyl 
transferase) and quinine reductase in the liver as well as 
in colon [41]. 
Several studies have suggested that the intestinal 
flora influence the process of carcinogenesis by 
producing enzymes (glycosidase, β-glucuronidase, 
azo-reductase and nitro-reductase), which transform 
pre-carcinogens into active carcinogens [28, 31]. 
β-glucuronidase hydrolyses glucuronides to liberate 
carcinogenic aglycones in the intestinal lumen. In the 
present study, feeding rats with PXC or probiotic Dahi 
diminished the DMH induced rise in β-glucuronidase 
activity in faeces, and the probiotic LaLp Dahi was 
more effective than PXC. Combined probiotic Dahi and 
PXC were more efficacious in attenuation of DMH 
induced rise in β-glucuronidase activity in faeces. These 
results are in agreement with earlier reports from our 
laboratory [32]. These results are similar to earlier 
studies [33], where oral ingestion of different probiotic 
strains reduced the bacterial β-glucuronidase, 
nitroreductase and azoreductase activities in faeces. 
The liver inhabits a vital role in the main functions of 
the organism. It is particularly susceptible to chemically 
induced damage due to its extensive metabolic capacity 
and cellular heterogeneity. Lipid peroxidation has been 
implicated in the pathogenesis of a variety of diseases 
including cancer [34]. Studies have shown increased 
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levels of lipid peroxidation in the tumor tissue [34, 35]. 
In the present study, the accumulation of lipid 
peroxidation product- TBARS in liver increased with 
age, and the treatment with DMH resulted in 3-4 fold 
increase in accumulation of TBARS in liver and 
colorectal tissue. These findings are in accordance with 
the increased concentration of malondialdehyde 
observed in plasma and tissues of colorectal cancer 
patients [36]. Increased TBARS levels in the liver and 
colorectum of DMH-treated animals could be due to 
toxicity caused by DMH. The treatment with PXC or 
feeding probiotic Dahi significantly attenuated the 
DMH induced rise in accumulation of TBARS in liver 
and colorectal tissue. Probiotic LaLp Dahi was more 
effective than PXC in attenuation of DMH induced rise 
in TBARS accumulation. Treatment with combined 
PXC and probiotic Dahi was more efficacious in 
attenuation of TBARS accumulation. These results are 
similar to those of Yadav et al. who observed that oral 
ingestion of probiotic Dahi reduced the oxidative stress 
marker TBARS in rat intestinal tissues [37]. Recent 
study from our laboratory [32] also showed that 
probiotic Dahi could act as an antioxidant and can 
inhibit lipid peroxidation. However, future research may 
be needed to explore the molecular mechanism 
underlying the anticarcinogenic potential of probiotic 
Dahi alone or in combination of PXC to alleviate or 
reduce the colorectal carcinogenic effects of DMH. 
Conclusion 
In summary, the present study reveals that probiotic 
Dahi that is administered individually or in combination 
with PXC to experimental rats possesses a potent 
protective effect against DMH-induced colorectal 
carcinogenesis. These findings suggest that probiotic 
Dahi could have a therapeutic potential to decrease the 
risk of colorectal cancer and be used as a potential 
nutraceutical intervention in prophylaxis and treatment 
of colorectal cancer. This study also demonstrated that 
traditionally used dairy-based fermented foods may be 
successfully used a potential medium for the delivery of 
probiotics to achieve anticarcinogenic health-benefits to 
the consumers.  
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